{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:54:20Z","timestamp":1789080860848,"version":"build-2803163510"},"reference-count":42,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Development of FVIII inhibitors is currently the most severe and challenging complication of haemophilia A treatment and represents a very large economic burden for a chronic disease. As a result, clinical research is making major efforts to optimize the therapeutic approaches for this condition. In this section we will review some important aspects of the management of haemophilia in adults, including an overview of bleeding in women with von Willebrand disease, an analysis of FVIII consumption in patients with severe haemophilia A, an update of the ongoing RES.I.ST study, long\u2010term prophylaxis and experience from the Pro.Will study, current evidence relating to economic aspects of the treatment of haemophilic patients with inhibitors (based on the PROFIT study), and an overview of musculoskeletal complications in adults with severe bleeding disorders.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2012.02797.x","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T21:30:48Z","timestamp":1335303048000},"page":"24-36","source":"Crossref","is-referenced-by-count":8,"title":["Management of bleeding disorders in adults"],"prefix":"10.1111","volume":"18","author":[{"given":"F.","family":"PEYVANDI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"KLAMROTH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CARCAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"FEDERICI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"DI MINNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"JIM\u00c9NEZ\u2010YUSTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"RODRIGUEZ MERCH\u00c1N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02269.x"},{"key":"e_1_2_14_3_2","unstructured":"ShawJA ShawHA.Menorrhagia. Medscape 2012 Available at:http:\/\/www.emedicine.com\/MED\/topic1449.htm. Accessed January 16 2012."},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00285.x"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00342.x"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00447.x"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb13514.x"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00991.x"},{"key":"e_1_2_14_9_2","first-page":"1","article-title":"von Willebrand\u2019s disease in Sweden","volume":"238","author":"Silwer J","year":"1973","journal-title":"Acta Paediatr Scand Suppl"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02563.x"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.02.036"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04372.x"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01189.x"},{"key":"e_1_2_14_15_2","unstructured":"United Kingdom Haemophilia Centres Doctors\u2019 Organisation.20092010."},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-369132"},{"issue":"4","key":"e_1_2_14_17_2","first-page":"16","article-title":"Immune tolerance induction (ITI) in haemophilia A patients with inhibitors \u2013 the choice of concentrate affecting success","volume":"86","author":"Kreuz W","year":"2001","journal-title":"Haematologica\/J Hematol"},{"issue":"9","key":"e_1_2_14_18_2","first-page":"17","article-title":"Epidemiology of inhibitors and current treatment strategies","volume":"88","author":"Kreuz W","year":"2003","journal-title":"Haematologica\/J Hematol"},{"issue":"9","key":"e_1_2_14_19_2","first-page":"21","article-title":"The role of plasma\u2010derived factor VIII\/von Willebrand factor concentrates in the treatment of hemophilia A patients","volume":"88","author":"Auerswald G","year":"2003","journal-title":"Haematologica\/J Hematol"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01560.x"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01484.x"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01296.x"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01497.x"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01579.x"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.450"},{"key":"e_1_2_14_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02088.x"},{"key":"e_1_2_14_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01573.x"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0941"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02100.x"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00368.x"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00321.x"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00849.x"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01370.x"},{"key":"e_1_2_14_34_2","first-page":"83","article-title":"Hemophilia treatment. Immune tolerance induction: treatment duration analysis and economic considerations","volume":"85","author":"Aledort LM","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00950.x"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01497.x"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03615.x"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01080.x"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<1025::AID-ANR23>3.0.CO;2-3"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0390"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-284653"},{"key":"e_1_2_14_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02615.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2012.02797.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2012.02797.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T02:56:02Z","timestamp":1694573762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2012.02797.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":42,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1111\/j.1365-2516.2012.02797.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02797.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]}}}